Vaxcyte, Inc. PCVX Unrealized Gain (Loss), Foreign Currency Transaction, after Tax
Unrealized Gain (Loss), Foreign Currency Transaction, after Tax at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s unrealized gain (loss), foreign currency transaction, after tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s unrealized gain (loss), foreign currency transaction, after tax?
- Vaxcyte, Inc. (PCVX) reported unrealized gain (loss), foreign currency transaction, after tax of -$2.2M in Q1 2026.
- How has Vaxcyte, Inc.'s unrealized gain (loss), foreign currency transaction, after tax changed year-over-year?
- Vaxcyte, Inc.'s unrealized gain (loss), foreign currency transaction, after tax decreased by 133.3% year-over-year, from $6.62M to -$2.2M.
- What does unrealized gain (loss), foreign currency transaction, after tax mean?
- This captures the non-cash impact of exchange rate fluctuations on monetary assets and liabilities denominated in currencies other than the company's functional currency. It reflects unrealized gains or losses that have not yet been settled through actual cash transactions. Monitoring this helps investors isolate the impact of currency volatility from core operational performance.